Necrotizing enterocolitis in an extremely preterm infant born to a mother with type 1 diabetes mellitus: a case report with focused literature review
DOI:
https://doi.org/10.18203/2320-6012.ijrms20262656Keywords:
Acute necrotizing enterocolitis, Prematurity, Type 1 diabetes mellitus, Infant of diabetic mother, Antenatal corticosteroids, Magnesium sulphate, Human milkAbstract
Necrotizing enterocolitis is a major cause of morbidity and mortality in very preterm infants. Maternal type 1 diabetes mellitus is strongly associated with prematurity, but its independent association with necrotizing enterocolitis remains uncertain. A 27-year-old woman with pregestational type 1 diabetes mellitus developed threatened preterm labour and later delivered a male infant at 27 weeks and 4 days of gestation weighing 880 g. The infant required intubation and surfactant therapy for extreme prematurity. During the neonatal course, he developed abdominal distension, bilious aspirates, worsening respiratory status, and mixed acidosis consistent with Bell stage IIA necrotizing enterocolitis. Management included bowel rest, gastric decompression, intravenous antibiotics, parenteral nutrition, close monitoring, and early surgical review. Feeds were later reintroduced using expressed breast milk, and the infant recovered without surgery, was discharged home, and remained well at follow-up, with appropriate growth and no recurrent gastrointestinal symptoms. Relevant cohort studies, meta-analyses, and guideline-level evidence regarding maternal type 1 diabetes mellitus, prematurity, and necrotizing enterocolitis were reviewed. Current evidence supports a strong association between maternal type 1 diabetes mellitus and prematurity, while evidence for an independent association with necrotizing enterocolitis remains inconsistent. This case emphasizes the importance of antenatal optimization, early neonatal stabilization, prompt recognition of intestinal disease, careful reintroduction of human milk feeding, and structured post-discharge follow-up.
References
Bellodas Sanchez J, Kadrofske M. Necrotizing enterocolitis. Neurogastroenterol Motil. 2019;31(3):e13569.
Niño DF, Sodhi CP, Hackam DJ. Necrotizing enterocolitis: new insights into pathogenesis and mechanisms. Nat Rev Gastroenterol Hepatol. 2016;13(10):590-600.
Thompson AM, Bizzarro MJ. Necrotizing enterocolitis in newborns: pathogenesis, prevention and management. Drugs. 2008;68(9):1227-38.
D’Angelo G, Impellizzeri P, Marseglia L, Montalto AS, Russo T, Salamone I, et al. Current status of laboratory and imaging diagnosis of neonatal necrotizing enterocolitis. Ital J Pediatr. 2018;44(1):84.
Alexander KM, Chan SS, Opfer E, Cuna A, Fraser JD, Sharif S, et al. Implementation of bowel ultrasound practice for the diagnosis and management of necrotising enterocolitis. Arch Dis Child Fetal Neonatal Ed. 2021;106(1):96-103.
Hu X, Liang H, Li F, Zhang R, Zhu Y, Zhu X, et al. Necrotizing enterocolitis: current understanding of the prevention and management. Pediatr Surg Int. 2024;40(1):32.
Thakkar HS, Lakhoo K. The surgical management of necrotising enterocolitis. Early Hum Dev. 2016;97:25-28.
Herrmann K, Carroll K. An exclusively human milk diet reduces necrotizing enterocolitis. Breastfeed Med. 2014;9:184-90.
Chandran S, Anand AJ, Rajadurai VS, Seyed ES, Khoo PC, Chua MC. Evidence-based practices reduce necrotizing enterocolitis and improve nutrition outcomes in very low birth weight infants. JPEN J Parenter Enteral Nutr. 2021;45:1408-16.
Shepherd E, Goldsmith S, Doyle LW, Middleton P, Marret S, Rouse DJ, et al. Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus. Cochrane Database Syst Rev. 2024;5:CD004661.
Walters A, McKinlay C, Middleton P, Harding JE, Crowther CA. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database Syst Rev. 2022;4:CD003935.
Crowther CA, Middleton PF, Voysey M, Askie L, Zhang S, Martlow TK, et al. Effects of repeat prenatal corticosteroids given to women at risk of preterm birth: an individual participant data meta-analysis. PLoS Med. 2019;16(4):e1002771.
Sweet DG, Carnielli VP, Greisen G, Hallman M, Klebermass-Schrehof K, Ozek E, et al. European consensus guidelines on the management of respiratory distress syndrome: 2022 update. Neonatology. 2023;120(1):3-23.
Sibai BM, Caritis SN, Thom E, Klebanoff M, McNellis D, Rocco L, et al. Preterm delivery in women with pregestational diabetes mellitus or chronic hypertension relative to women with uncomplicated pregnancies. Am J Obstet Gynecol. 2000;183:1520-24.
Evers IM, de Valk HW, Visser GHA. Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands. BMJ. 2004;328:915.
Ekbom P, Damm P, Feldt-Rasmussen B, Feldt-Rasmussen U, Molvig J, Mathiesen ER. Pregnancy outcome in type 1 diabetic women with microalbuminuria. Diabetes Care. 2001;24:1739-44.
Jensen DM, Damm P, Ovesen P, Mølsted-Pedersen L, Beck-Nielsen H, Westergaard JG, et al. Microalbuminuria, preeclampsia, and preterm delivery in pregnant women with type 1 diabetes. Diabetes Care. 2009;32:90-94.
Lepercq J, Coste J, Theau A, Dubois-Laforgue D, Timsit J. Factors associated with preterm delivery in women with type 1 diabetes: a cohort study. Diabetes Care. 2004;27(12):2824-8.
Grandi C, Tapia J, Cardoso VC. Impact of maternal diabetes mellitus on mortality and morbidity of very low birth weight infants: a multicenter Latin America study. J Pediatr (Rio J). 2015;91:234-41.
Boghossian NS, Hansen NI, Bell EF, Brumbaugh JE, Stoll BJ, Laptook AR, et al. Outcomes of extremely preterm infants born to insulin-dependent diabetic mothers. Pediatrics. 2016;137:e20153424.
Persson M, Shah PS, Rusconi F. Association of maternal diabetes with neonatal outcomes of very preterm and very low-birth-weight infants: an international cohort study. JAMA Pediatr. 2018;172(9):867-75.
Razak A, Faden M. Association of maternal diabetes mellitus with preterm infant outcomes: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2020;105:271-7.
March MI, Gupta M, Modest AM, Wu L, Hacker MR, Martin CR, et al. Maternal risk factors for neonatal necrotizing enterocolitis. J Matern Fetal Neonatal Med. 2015;28(11):1285-90.
Ahle M, Drott P, Elfvin A, Andersson RE. Maternal, fetal and perinatal factors associated with necrotizing enterocolitis in Sweden. A national case-control study. PLoS One. 2018;13(3):e0194352.
Huynh J, Dawson D, Roberts D, Bentley-Lewis R. Type 1, type 2 and gestational diabetes mellitus differentially impact placental pathologic characteristics of uteroplacental malperfusion. Placenta. 2015;36(10):1161-6.
Dix L, Roth-Kleiner M, Osterheld M. Placental vascular obstructive lesions: risk factor for developing necrotizing enterocolitis. Pathol Res Int. 2010;2010:838917.
Watson S, McElroy SJ. Potential prenatal origins of necrotizing enterocolitis. Gastroenterol Clin North Am. 2021;50(2):431-44.
Duci M, Fascetti-Leon F, Toffolutti T, Giovanna V, Piergiorgio G, Fascetti-Leon F, et al. Maternal and placental risk factors associated with the development of necrotizing enterocolitis and its severity. J Pediatr Surg. 2019;54(10):1202-7.
Garg P, Mestan K, Wong YP, Lauren B, Jennifer W, Kristin A, et al. Association of placental pathologic findings with the severity of necrotizing enterocolitis in preterm infants: a matched case-control study. Fetal Pediatr Pathol. 2022;41(2):187-97.
Downloads
Published
How to Cite
Issue
Section
